Latest Biotech News

Structure Therapeutics reported 44‑week Phase 2 data showing its oral GLP‑1 agonist aleniglipron produced up to ~16% placebo‑adjusted weight loss, reinforcing the company’s claim of...

CytomX reported expansion‑cohort data from a Phase 1 study of Varseta‑M, a ‘masked’ conditionally activated antibody‑drug conjugate targeting EpCAM, showing objective response rates of 20–32% at...

Bicycle Therapeutics announced a 30% workforce reduction and a strategic de‑prioritization of its Padcev challenger following an unexpected regulatory setback that extended the path to approval....

PerturbAI emerged from stealth and publicly released an in‑vivo Perturb‑seq CRISPR atlas mapping gene function across 8 million mouse brain cells, generated with partners 10x Genomics, NVIDIA and...

Roche expanded its AI and compute ambitions by striking a deal with Nvidia to build an ‘AI factory’ intended to accelerate drug discovery and diagnostic development. The initiative follows a...

Researchers at the University of Basel published weMERFISH, an extension of MERFISH that enables three‑dimensional, whole‑embryo spatial transcriptomics over time. The platform detected...

ARPA‑H awarded BioCurie up to $9.3 million to develop an AI‑powered digital platform intended to speed and standardize gene therapy process development across viral and non‑viral manufacturing....

Trenchant BioSystems and Invetech announced a collaboration to commercialize AutoCell, a fully automated cell and gene therapy (CGT) manufacturing platform that could enable point‑of‑care...

PerturbAI announced it has emerged from stealth and publicly released an in vivo CRISPR Perturb‑seq atlas mapping gene function across 8 million mouse brain cells. The San Francisco startup...

EMBL‑EBI, DeepMind, NVIDIA and Seoul National University jointly released a large-scale set of AI‑predicted protein complex structures to the AlphaFold Database, dramatically expanding resources...

Researchers published a Nature Biotechnology paper detailing a generative‑model framework that enables petascale synthesis of designed DNA sequences for engineered biology and cell‑therapy...

Roche announced a strategic deal with NVIDIA to build an AI 'factory' aimed at accelerating drug and diagnostic development, positioning the Swiss group to compete with peers investing in...

Mayo Clinic researchers published preclinical work on milk‑derived nanoparticles engineered to deliver targeted gene therapy to cholangiocarcinoma, an aggressive bile duct cancer. The team showed...

Structure Therapeutics released 44‑week Phase 2 data showing its oral GLP‑1 candidate aleniglipron produced up to 16% placebo‑adjusted weight loss, positioning the pill as a competitive oral...

BioMarin said it will halt dosing in certain patients across two mid‑stage Voxzogo studies after investigators flagged hip‑related safety events—cases of slipped capital femoral epiphysis...

R1 Therapeutics secured $77.5 million to advance a Phase 2b program targeting hyperphosphatemia in dialysis patients and support clinical development toward a potential market launch by the...

ARPA‑H awarded BioCurie up to $9.3 million to develop an AI‑powered digital platform designed to accelerate and standardize gene therapy manufacturing across viral and non‑viral modalities....

Trenchant BioSystems announced a collaboration with Invetech to advance and commercialize the AutoCell platform, a fully automated cell and gene therapy (CGT) manufacturing system intended for...

Structure Therapeutics announced Phase 2 data showing its oral GLP‑1 candidate aleniglipron produced roughly 16% placebo‑adjusted weight loss at 44 weeks. The company reported durable efficacy...

CytomX Therapeutics disclosed expansion‑cohort Phase 1 data for its masked antibody‑drug conjugate Varseta‑M showing objective response rates of roughly 20–32% in heavily pretreated metastatic...